Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioPharmX Corporation BPMX

Healthcare Biotechnology
"BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated with drug therapies or drug delivery approaches that... see more

Recent & Breaking News (NYSEAM:BPMX)

BioPharmX Completes Enrollment in Phase 2b Trial of BPX-04 for Patients with Papulopustular Rosacea

PR Newswire March 4, 2019

BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American

PR Newswire February 27, 2019

BioPharmX Strengthens Board of Directors with Appointment of Industry Veteran Dr. R. Todd Plott

PR Newswire February 4, 2019

Thinking about buying stock in Apple, BioPharmX, China Ceramics Co., Netflix or Weatherford International?

PR Newswire January 2, 2019

BioPharmX Receives Notice of Noncompliance from NYSE American

PR Newswire December 20, 2018

BioPharmX Reports Third Quarter 2019 Financial Results

PR Newswire December 6, 2018

BioPharmX Announces NYSE American Acceptance of Plan To Regain Listing Compliance

PR Newswire November 16, 2018

BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea

PR Newswire October 11, 2018

BioPharmX Receives Notice of Noncompliance from NYSE American

PR Newswire September 28, 2018

BioPharmX Corporation Announces David S. Tierney, M.D. Joined the Company as Chief Executive Officer

PR Newswire September 12, 2018

BioPharmX Reports Second Quarter 2019 Financial Results

PR Newswire August 30, 2018

Detailed Research: Economic Perspectives on Allegheny Technologies, Ring Energy, Aerohive Networks, Omeros, Adtalem Global Education, and BioPharmX — What Drives Growth in Today's Competitive Landscape

GlobeNewswire August 28, 2018

BioPharmX Announces Results of Annual Shareholders Meeting

PR Newswire August 14, 2018

BioPharmX Announces Patent Award, Expanding Protection for Innovations in Solid Dosage Forms

PR Newswire August 9, 2018

BioPharmX Receives IRB Approval to Initiate Phase 2 Trial of BPX-04 for the Treatment of Rosacea

PR Newswire July 31, 2018

Report: Developing Opportunities within Valvoline, Parker Drilling, Dean Foods, BioPharmX, Hasbro, and Alnylam Pharmaceuticals — Future Expectations, Projections Moving into 2018

GlobeNewswire June 27, 2018

New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatology

PR Newswire June 19, 2018

BioPharmX Reports First Quarter 2019 Financial Results

PR Newswire June 7, 2018

BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients

PR Newswire May 24, 2018

BioPharmX Reports Fourth Quarter and Full Year 2018 Financial Results

PR Newswire April 26, 2018